Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 93,806 shares at $140.99 ($13.1M) on 2020-05-21, disclosed to the SEC on 2020-05-26.
Seasonal sale ($13.1M) by Chief Executive Officer — this insider has traded RGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.17 | 16,496 | $2.3M | 17.5% |
| 2 | $139.17 | 16,496 | $2.3M | 17.5% |
| 3 | $140.04 | 28,980 | $4.1M | 31.0% |
| 4 | $140.04 | 28,980 | $4.1M | 31.0% |
| 5 | $140.99 | 1,377 | $194K | 1.5% |
| 6 | $140.99 | 1,377 |
| $194K |
| 1.5% |
| 7 | $141.58 | 100 | $14K | 0.1% |
| Total | $139.76 avg | 93,806 | $13.1M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |